Concepedia

Author

Nikita Mehta

Memorial Sloan Kettering Cancer CenterORCID

Also Known As

Mehta, Nikita, Nikita Mehta, Nikita N Mehta, Nikita N. Mehta, the FDA approved Pembrolizumab to treat any mismatch repair deficient (dMMR) tumor. MMR immunohistochemistry (IHC) testing then increased across all tumor types. For the first time

41

Publications

602

Citations

14

H-Index

39

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterCornell UniversityMolecular Oncology (United States)University of ChicagoEmory University
NM

About

Nikita Mehta is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, molecular diagnostics, and genetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

157

2

Engineering

1

1

15

3

Law

1

1

15

4

Public Health

1

1

70

5

Epidemiology

1

1

70

Nikita Mehta

×

15

Publications

546

Citations

13

H-Index

YearCitations

Page 1